Open reading frame 37 (ORF37) of Varicella zoster encodes for envelope glycoprotein H (gH). VZV gH is a 118kDa type 1 transmembrane glycoprotein highly conserved among other alphaherpesviruses. VZV gH forms heterodimer with gL (ORF60) and together with gB (ORF31) makes a core fusion machinery required for cell fusion and forming syncytia (Viruses (2012) 4, 800-32). To be functionally competent VZV gH needs chaperone activity of gL. VZV gH is transported and inserted within the plasma membrane, and it was shown that it is endocytosed thus regulating extent of cell-cell fusion (Journal of Virology (2004) 78, 2884–2896). Our anti-VZV ORF37 antibody VZ37.12 works in ELISA (on immunogen) and each LOT is validated for Western blot (of VZV infected cell lysates, described in J Virol. 2013 Jun;87(12):6943-54.).
Clone: VZ 37.12
Catalog No.: HR-VZV-22
Host Species: Mouse
Reactivity: Varicella zoster virus
Antigen/Immunogen: The immunogen was a peptide of VZV ORF37 protein fused to a carrier
Tested Applications: ELISA; WB
Recommended Dilution: n/a
Varicella zoster virus
The immunogen was a peptide of VZV ORF37 protein fused to a carrier
€200.00 – €700.00
|STORAGE||Long term -20 °C, short term +4 °C. Avoid freeze-thaw cycles.|
|LIGHT CHAIN TYPE||kappa|
|REFERENCES||Lenac et al., J Virol, 2013|
The ORF50 gene of the varicella-zoster virus (VZV) encodes glycoprotein M which is conserved among all herpesviruses. VZV gM is predicted to be an eight-transmembrane envelope glycoprotein modified with a complex N-linked oligosaccharide.
VZV ORF19 encodes a large, N-terminal subunit 1 of the viral ribonucleotide reductase, which together with the small subunit, encoded by the VZV ORF 18, forms the ribonucleotide reductase holoenzyme complex (RNR).